Table 1.

Association analysis of PDCD5 expression in endometrioid adenocarcinoma tissues and clinicopathologic parameters

Clinical and pathological features	PDCD5 expression
	n	Negative-moderate	Strong	P value
Age
≤55	20	17	3	0.3359
>55	30	28	2
Myometrial invasion (%)
≤50	31	27	4	0.8192
>50	19	18	1
FIGO stage
IA–IB	33	29	4	0.4861
IC–II	17	16	1
Tumor differentiation degree
High differentiation	11	8	3	0.0278*
Middle-low differentiation	40	38	2
Estrogen receptor
Negative-weak	11	10	1	0.7703
Moderate-strong	31	29	2
Progestin receptor
Negative-weak	11	10	1	0.7703
Moderate-strong	31	29	2

* P<0.05